Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Merck
Mallinckrodt
Express Scripts
Medtronic

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Gallium dotatate ga-68 - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for gallium dotatate ga-68 and what is the scope of patent protection?

Gallium dotatate ga-68 is the generic ingredient in one branded drug marketed by Aaa Usa Inc and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Gallium dotatate ga-68 has twenty-five patent family members in eighteen countries.

There are sixteen drug master file entries for gallium dotatate ga-68. One supplier is listed for this compound.

Summary for gallium dotatate ga-68
International Patents:25
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 16
Suppliers / Packagers: 1
Clinical Trials: 11
DailyMed Link:gallium dotatate ga-68 at DailyMed
Recent Clinical Trials for gallium dotatate ga-68

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 2
Assistance Publique - Hôpitaux de ParisPhase 3
National Cancer Institute (NCI)Early Phase 1

See all gallium dotatate ga-68 clinical trials

US Patents and Regulatory Information for gallium dotatate ga-68

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes   Start Trial   Start Trial   Start Trial
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Merck
Dow
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.